首页> 外国专利> RXR homodimer formation and bridged bicyclic aromatic compounds and their use in regulated gene expression

RXR homodimer formation and bridged bicyclic aromatic compounds and their use in regulated gene expression

机译:RXR同二聚体形成和桥联的双环芳族化合物及其在调控基因表达中的应用

摘要

The invention provides a method of screening a substance for the ability to affect the formation of a retinoid X receptor homodimer comprising combining the substance and a solution containing retinoid X receptors and determining the presence of homodimer formation. The screening method can be used to determine compounds which selectively activate homodimer formation and heterodimer formation. Also provided is a method of screening a substance for an effect on a retinoid X receptor homodimer's ability to bind DNA comprising combining the substance with the homodimer and determining the effect of the compound on the homodimer's ability to bind DNA. Finally, the invention provides methods of activating retinoid X receptor homodimer formation. Bridged bicyclic aromatic compounds are provided having structure (I); wherein R1, R2, R3, R4, R5 and n are as defined herein. The compounds are useful for modulating gene expression of retinoic acid receptors, vitamin D receptors and thyroid receptors. Pharmaceutical compositions and methods for modulating gene expression are provided as well.
机译:本发明提供了一种筛选具有影响类视黄醇X受体同二聚体形成能力的物质的方法,该方法包括将该物质与含有类视黄醇X受体的溶液合并并确定同二聚体形成的存在。筛选方法可用于确定选择性激活同型二聚体和异型二聚体的化合物。还提供了一种筛选对类视黄醇X受体同型二聚体结合DNA的能力有影响的物质的方法,该方法包括将该物质与同型二聚体结合并确定化合物对同型二聚体对DNA的结合能力的影响。最后,本发明提供了活化类视黄醇X受体同源二聚体形成的方法。提供具有结构(I)的桥连双环芳族化合物;其中R 1,R 2,R 3,R 4,R 5和n如本文所定义。所述化合物可用于调节视黄酸受体,维生素D受体和甲状腺受体的基因表达。还提供了用于调节基因表达的药物组合物和方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号